About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The goal of the Shock, Organic Dysfunction and Resuscitation Research Group (SODIR) is comprehensive, innovative research into the areas of shock, acute respiratory failure, acute kidney failure, organic dysfunction, resuscitation and critical patient monitoring. In addition, the research group has a special interest in applying artificial intelligence as an instrument to find innovative solutions for critical patients.
PMID: 35012662 Journal: CRITICAL CARE Year: 2022 Reference: Crit Care. 2022 Jan 10;26(1):18. doi: 10.1186/s13054-021-03882-1. Impact factor: 9.097 Publication type: Paper in international publication Authors: de Batlle, Jordi, Gomez, Silvia, Moncusi-Moix, Anna, Carmona, Paola, Santisteve, Sally, Monge, Aida, Gort-Paniello, Clara, Zuil, Maria, Cabo-Gambin, Ramon, Manzano Senra, Carlos et al. DOI: 10.1186/s13054-021-03882-1
PMID: 34996993 Journal: Scientific Reports Year: 2022 Reference: Sci Rep. 2022 Jan 7;12(1):28. doi: 10.1038/s41598-021-03970-w. Impact factor: 4.38 Publication type: Paper in international publication Authors: Renes Carreno, Emilio, Escriba Barcena, Almudena, Catalan Gonzalez, Mercedes, Alvarez Lerma, Francisco, Palomar Martinez, Mercedes, Nuvials Casals, Xavier, Jaen Herreros, Felisa, Montejo Gonzalez, Juan Carlos et al. DOI: 10.1038/s41598-021-03970-w
PMID: 34867954 Journal: Frontiers in Immunology Year: 2021 Reference: Front Immunol. 2021 Nov 17;12:734652. doi: 10.3389/fimmu.2021.734652. eCollection 2021. Impact factor: 7.561 Publication type: Paper in international publication Authors: Morante-Palacios, Octavio, Lorente-Sorolla, Clara, Ciudad, Laura, Calafell-Segura, Josep, Garcia-Gomez, Antonio, Catala-Moll, Francesc, Ruiz-Sanmartin, Adolfo, Martinez-Gallo, Monica, Ferrer, Ricard, Ruiz-Rodriguez, Juan Carlos et al. DOI: 10.3389/fimmu.2021.734652
PMID: 34825976 Journal: Annals of Intensive Care Year: 2021 Reference: Ann Intensive Care. 2021 Nov 26;11(1):159. doi: 10.1186/s13613-021-00951-0. Impact factor: 6.925 Publication type: Paper in international publication Authors: Moreno, Gerard, Carbonell, Raquel, Martin-Loeches, Ignacio, Sole-Violan, Jordi, Correig I Fraga, Eudald, Gomez, Josep, Ruiz-Botella, Manuel, Trefler, Sandra, Bodi, Maria, Murcia Paya, Josefa et al. DOI: 10.1186/s13613-021-00951-0
PMID: 34806858 Journal: Revista Espanola de Quimioterapia Year: 2021 Reference: Rev Esp Quimioter. 2021 Nov 22. doi: 10.37201/req/096.2021. Impact factor: 1.553 Publication type: Paper in international publication Authors: Lara, N, McCann, E, Fenoll, R, Gomez-Ulloa, D, Lozano, V, Lopez, D, Ferrer, R, Farinas, M C, Maseda, E, Salavert, M et al. DOI: 10.37201/req/096.2021
PMID: 34751263 Journal: The Lancet regional health. Europe Year: 2021 Reference: Lancet Reg Health Eur. 2021 Dec;11:100243. doi: 10.1016/j.lanepe.2021.100243. Epub 2021 Nov 4. Impact factor: 0 Publication type: Paper in international publication Authors: Ballesteros, Juan Carlos, Papiol, Elisabeth, Vina, Lucia, Sancho, Susana, Nieto, Mercedes, Lorente, Maria Del Carmen, Badallo, Oihane, Fraile, Virginia, Armestar, Fernando, Estella, Angel et al. DOI: 10.1016/j.lanepe.2021.100243
On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.
Hybrids VITA, developed together with Medical Simulator, reproduces different clinical scenarios for training on how to prevent, diagnose and treat possible complications of ECMO, which is a very complex technique.
Extracorporeal Cardiopulmonary Resuscitation (ECPR) offers therapeutic options for patients in whom conventional cardiopulmonary resuscitation techniques fail to restore the heartbeat.
